Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival
Authors:
- 2 June 2004
- journal article
- Published by Wiley in Histopathology
- Vol. 44 (6) , 555-560
Abstract
Aim: To assess the potential prognostic significance of a range of molecular and morphological parameters in glioblastomas that can be applied in the setting of a routine diagnostic neuropathology laboratory. Methods and results: A consecutive series of 107 adult glioblastomas were studied. Retinoblastoma and deleted-in-colon cancer (DCC) protein expression were assessed using immunocytochemistry and chromosome 10 loss by in-situ hybridization. Loss of retinoblastoma expression was associated with a worse outcome, which appeared to be independent of age. There was no significant association between chromosome 10 loss or DCC protein expression and survival. Survival was significantly increased in the 5% of patients whose tumours had focal morphological features suggesting oligodendroglial differentiation. Conclusions: Glioblastomas containing areas of oligodendroglial differentiation or showing widespread immunocytochemical expression of retinoblastoma protein have a better prognosis than those without these features.Keywords
This publication has 19 references indexed in Scilit:
- Impact of Genotype and Morphology on the Prognosis of GlioblastomaJournal of Neuropathology & Experimental Neurology, 2002
- Evaluation of Molecular Markers in Low-Grade Diffuse AstrocytomasAmerican Journal of Surgical Pathology, 2002
- Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survivalJournal of Clinical Pathology, 2001
- Analysis of loss of heterozygosity for chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survivalJournal of Neurosurgery, 2001
- Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular StudyJournal of Neuropathology & Experimental Neurology, 2001
- Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System TumorsJournal of Neuropathology & Experimental Neurology, 2000
- Prognostic Value of the Expression of Tumor Suppressor Genes p53, p21, p16 and pRb, and Ki-67 Labelling in High Grade Astrocytomas Treated with RadiotherapyJournal of Neuro-Oncology, 2000
- Induction of apoptosis and G2/M cell cycle arrest by DCCOncogene, 1999
- Malignant cerebral glioma—I: Survival, disability, and morbidity after radiotherapyBMJ, 1996
- Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomasJournal of Neurosurgery, 1995